Lovastatin and Avandaryl drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lovastatin (lovastatin) and Avandaryl (glimepiride; rosiglitazone maleate). Common drug interactions include deformity among females and coronary artery disease among males.

The phase IV clinical study analyzes what interactions people have when they take Lovastatin and Avandaryl. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Lovastatin?

Lovastatin has active ingredients of lovastatin. It is often used in high blood cholesterol. eHealthMe is studying from 33,048 Lovastatin users. Check the latest studies of Lovastatin.

What is Avandaryl?

Avandaryl has active ingredients of glimepiride; rosiglitazone maleate. It is often used in diabetes. eHealthMe is studying from 2,660 Avandaryl users. Check the latest studies of Avandaryl.



On Jul, 26, 2026

11 people who take Lovastatin and Avandaryl together, and have interactions are studied.

Lovastatin and Avandaryl drug interactions.

What are the common drug interactions of Lovastatin and Avandaryl, by gender? *:

female:

  1. Deformity (disfigurement)
  2. Dizziness
  3. Nausea (feeling of having an urge to vomit)
  4. Nervous system disorder (a general class of medical conditions affecting the nervous system)
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  6. Decreased appetite
  7. Dental caries
  8. Enterococcus test positive
  9. Extrapyramidal disorder (involuntary muscle spasms in the face and neck)
  10. Gastroenteritis (inflammation of stomach and intestine)

male:

  1. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  2. Emotional distress
  3. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  4. Pain
  5. Quality of life decreased
  6. Weight increased

What are the common drug interactions of Lovastatin and Avandaryl, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Mitral valve incompetence (inefficient heart valve)
  2. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  3. Cardiac disorder
  4. Swelling
  5. Abdominal pain
  6. Actinomycosis (infection that causes sores, or abscesses)
  7. Activated partial thromboplastin time prolonged
  8. Activities of daily living impaired
  9. Anaemia (lack of blood)
  10. Angina pectoris (chest pain due to ischemia of the heart muscle)

60+:

  1. Dizziness
  2. Headache (pain in head)
  3. Dyskinesia (abnormality or impairment of voluntary movement)
  4. Enterococcus test positive
  5. Extrapyramidal disorder (involuntary muscle spasms in the face and neck)
  6. Fibromyalgia (a long-term condition which causes pain all over the body)
  7. Gastritis (inflammation of stomach)
  8. Gastroenteritis (inflammation of stomach and intestine)
  9. Gingival pain (gum pain)
  10. Hypoglycaemia (deficiency of glucose in the bloodstream)

What are the existing conditions these people have? *

  1. Indigestion: 2 people, 18.18%
  2. Gastrointestinal Disorder (functional problems of gastrointestinal tract): 2 people, 18.18%
  3. Type 2 Diabetes: 1 person, 9.09%
  4. Hypercalcaemia Of Malignancy (elevated calcium (ca+) level in the blood with cancer): 1 person, 9.09%
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 1 person, 9.09%
  6. Abdominal Pain: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Lovastatin and Avandaryl?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lovastatin and Avandaryl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lovastatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Avandaryl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lovastatin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Avandaryl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lovastatin and glimepiride; rosiglitazone maleate (the active ingredients of Lovastatin and Avandaryl, respectively), and Lovastatin and Avandaryl (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: